FAS and neoplasm: RXLD exert an eligible therapeutic effect in rat bladder cancer by inducing Fas pathway-related cell apoptosis and inhibiting VEGF regulated tumor angiogenesis in vivo (22).Therefore, we hypothesized that RXLD has an eligible medicinal value, and its anti-tumor effect is worth exploring.